Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial
Myhre PL, Berge T, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Solheim S, Arnesen H, Seljeflot I, Tveit A · Clinical nutrition (Edinburgh, Scotland)
Background & aims : Recent randomized clinical trials have raised concerns regarding potential off target adverse effects from supplementation of n-3 polyunsaturated fatty acids (PUFA) on atrial fibrillation (AF) risk. We aimed to assess risk and potential mediators of AF and 'micro-AF' from n-3 PUFA in…